Clinical Omics – News and Features

Selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1, a rare genetic disease for which there is currently no effective pharmacological treatment.

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Researchers have developed a new machine learning algorithm, SAVANA, which can accurately identify cancer-specific structural variations and copy number aberrations in long-read DNA sequencing data, informing cancer diagnosis and interventions.

Discover how epiproteomics unlocks new biomarkers and drives breakthroughs in diagnostics and drug development.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

Next-generation proteomics is enabling researchers to explore the proteome with unprecedented depth and scale. This article will explore recent advances in the application of high-throughput proteomics in precision medicine.

Flow cytometry (FC) is a powerful tool for multi-parametric cell characterization. In this article, we explore the advances improving the accuracy and efficiency of FC and opening up new research and clinical applications.

Parag Mallick, Stanford scientist and Nautilus co-founder, is looking to transform proteomics with a platform for proteome-wide analysis, advancing diagnostics and disease research.

Clinical uses of mass spectrometry have historically been limited to specialist facilities. A new solution from Roche automates the entire workflow enabling routine testing laboratories to capitalize on the high sensitivity of mass spectrometry.

Professor Jennifer Van Eyk joined Technology Networks for an exclusive interview at HUPO 2024 to discuss progress and bottlenecks in clinical proteomics